These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 4216115)
21. Factor-XIII subunits-A and -S in congenital deficiency and in acute myeloblastic leukemia. Barbui T; Rodeghiero F; Dini E Haematologica; 1974 Dec; 59(4):458-66. PubMed ID: 4219003 [No Abstract] [Full Text] [Related]
22. A new inherited coagulation disorder caused by an abnormal fibrinogen ('fibrinogen Baltimore'). Beck EA; Charache P; Jackson DP Nature; 1965 Oct; 208(5006):143-5. PubMed ID: 4956920 [No Abstract] [Full Text] [Related]
23. Experimental dysfibrinogenemia: in vivo studies with arvin. Rodriguez-Erdmann F; Carpenter CB; Galvanek EG Blood; 1971 Jun; 37(6):664-74. PubMed ID: 5162311 [No Abstract] [Full Text] [Related]
24. Quantitation of the coagulation inhibition in vivo due to breakdown products of fibrin. Mitchell PS; Beller FK Thromb Diath Haemorrh; 1970 Jun; 23(3):477-85. PubMed ID: 4989113 [No Abstract] [Full Text] [Related]
25. Fibrinogen New Orleans: hereditary dysfibrinogenemia with an A alpha chain abnormality. Andes WA; Chavin SI; Beltran G; Stuckey WJ Thromb Res; 1982 Jan 1-15; 25(1-2):41-50. PubMed ID: 6801812 [TBL] [Abstract][Full Text] [Related]
26. Spontaneous consumption coagulopathy in a dog with thyroid cancer. Slappendel RJ; de Maat CE; Rijnberk A; van Arkel C Thromb Diath Haemorrh; 1970 Oct; 24(1):129-35. PubMed ID: 4991803 [No Abstract] [Full Text] [Related]
28. Fibrinogen Troyes--fibrinogen Metz. Two new cases of congenital dysfibrinogenemia. Soria J; Soria C; Samama M; Poirot E; Kling C Thromb Diath Haemorrh; 1972 Jul; 27(3):619-33. PubMed ID: 4662617 [No Abstract] [Full Text] [Related]
29. [Congenital dysfibrinogenemia. Apropos of 13 cases]. Corrihons G; Soria J; Soria C; Conard J; Horellou MH; Samama M Sem Hop; 1983 Oct; 59(36):2517-23. PubMed ID: 6316508 [TBL] [Abstract][Full Text] [Related]
31. [Evaluation of coagulation factor XIII. Critical study of the different techniques used (author's transl)]. Soria J; Soria C; Lafay P Pathol Biol (Paris); 1980 May; 28(5):313-7. PubMed ID: 6770323 [TBL] [Abstract][Full Text] [Related]
33. Inherited fibrinolytic disorder due to an enhanced plasminogen activator level. Aznar J; Estellés A; Vila V; Regañón E; España F; Villa P Thromb Haemost; 1984 Oct; 52(2):196-200. PubMed ID: 6543037 [TBL] [Abstract][Full Text] [Related]
34. Fibrinogen Montreal. A new case of congenital dysfibrinogenemia with defective aggregation of monomers. Lacombe M; Soria J; Soria C; D'Angelo G; Lavallee R; Bonny Y Thromb Diath Haemorrh; 1973 Jun; 29(3):536-46. PubMed ID: 4761822 [No Abstract] [Full Text] [Related]
38. Masugi nephritis: the renal lesion and the coagulation processes. Borrero J; Todd ME; Becker CG; Becker EL Clin Nephrol; 1972; 1(2):86-93. PubMed ID: 4669792 [No Abstract] [Full Text] [Related]
39. Hypofibrinogenemia-dysfibrinogenemia and von Willebrand's disease in the same family. Owen CA; Bowie EJ; Fass DN; Perez RA; Cole TL; Stewart M Mayo Clin Proc; 1979 Jun; 54(6):375-80. PubMed ID: 312982 [TBL] [Abstract][Full Text] [Related]